SCHEMBL25954187

SCHEMBL25954187

CN(C)C(=O)Cn1ccc(=O)c2ccc(-c3ccccc3Oc3ccc(C(F)(F)F)cc3)cc21

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GRIN2B Q13224 17/20 0.50
▸ GRIN1 Q05586 7/20 0.50
▸ TRPV1 Q8NER1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25429484 0.84 SCN8A (0.43) TRPV1
SCHEMBL25429756 0.83 ICMT (0.39) TRPV1
SCHEMBL30544045 0.83 ICMT (0.39) TRPV1
SCHEMBL30544057 0.83 SCN9A (0.44) TRPV1
SCHEMBL25952320 0.83 SCN9A (0.44) TRPV1
SCHEMBL25429629 0.82 TRPV1 (0.46) TRPV1
SCHEMBL25428113 0.81 TRPV1 (0.39) TRPV1
SCHEMBL30544026 0.81 TRPV1 (0.39) TRPV1
SCHEMBL25429273 0.80 NOD2 (0.37) TRPV1
SCHEMBL30544106 0.79 PDPK1 (0.40) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback